|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Tokai Gets $23M, Eleven Therapeutics Hires New CEO, Ariad Drug Advances, & More Boston-Area Life Sciences News
|
Erin Kutz |
09/23/11 |
Boston
|
|
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News
|
Erin Kutz |
09/21/11 |
Boston
|
|
Tokai Snaps Up $23M From Novartis and Apple Tree to Challenge Leaders in Prostate Cancer
|
Luke Timmerman |
09/20/11 |
Boston
|
|
Tokai Pharmaceuticals Obtains $23,000,000 Series D Financing Round
|
VentureDeal |
09/20/11 |
Boston
|
|
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs
|
Gregory T. Huang |
08/24/10 |
Boston
|
|
Celgene Agrees to Acquire Gloucester Pharma for $340M Cash Upfront, $300M Later
|
Luke Timmerman |
12/07/09 |
Boston
|
|
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer
|
Luke Timmerman |
11/05/09 |
Boston
|
|
Top 10 (+ 1) New England Venture Deals of Q3 2009
|
Robert Buderi |
10/20/09 |
Boston
|
|
Gloucester Wins Recommendation from FDA Panel for Lymphoma Drug
|
Luke Timmerman |
09/02/09 |
Boston
|
|
Resolvyx Nails Dry Eye Trial, Gloucester Pulls in $29M, Shire Beefs Up Mass Presence, & Other Boston-Area Life Sciences News
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Gloucester Nails Down $29M to Move Ahead with Late-Stage Cancer Drug
|
Luke Timmerman |
08/24/09 |
Boston
|
|
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List
|
Ryan McBride |
07/21/09 |
Boston
|
|
Aileron Piles on $40M, GenArts Lights Up Lucasfilm’s Screens, Taris Takes on $15M, & More Boston-Area Deals News
|
Rebecca Zacks |
06/12/09 |
Boston
|
|
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/10/09 |
Boston
|
|
Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs
|
Luke Timmerman |
06/08/09 |
Boston
|
|
Aileron Therapeutics, Inc Garners $40,000,000 Series D Round
|
VentureDeal |
06/08/09 |
Boston
|
|
Genzyme Targets Growth, Taligen Takes $26M, Icahn Lays Into Biogen Idec Management, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/13/09 |
Boston
|
|
Battery Ventures Backs ExactTarget, $22M for Tokai Pharmaceuticals, Ironwood Banks $40M in European Deal, & Much Much More Boston-Area Deals News
|
Rebecca Zacks |
05/11/09 |
Boston
|
|
Tokai Pharmaceuticals Lands $22,000,000 Series D Funding Round
|
VentureDeal |
05/08/09 |
Boston
|
|
Tokai Pharma Reports $22M Round, Developing Drug for Prostate Cancer
|
Ryan McBride |
05/07/09 |
Boston
|
|
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News
|
Rebecca Zacks |
04/16/08 |
Boston
|
|
Aileron Raises $10 Million
|
Robert Buderi |
04/15/08 |
Boston
|
|
Aileron Therapeutics, Inc. Receives $10,000,000 New Funding Round
|
VentureDeal |
04/15/08 |
Boston
|
|
Aileron Therapeutics, Inc. Obtains $10,000,000 New Financing Round
|
VentureDeal |
12/31/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.